Pain Therapeutics, Inc., a biopharmaceutical company, develops drugs for treating nervous system in the United States. The companys lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimers disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.
